Actinium Pharmaceuticals
ATNM
ATNM
40 hedge funds and large institutions have $5.8M invested in Actinium Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
9% less funds holding
Funds holding: 44 → 40 (-4)
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Holders
40
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$373K | |
| 2 | +$246K | |
| 3 | +$104K | |
| 4 |
Renaissance Technologies
New York
|
+$66.4K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$35K |
Top Sellers
| 1 | -$259K | |
| 2 | -$147K | |
| 3 | -$16K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$13K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$8K |